Compounds > torcetrapib
Page last updated: 2024-09-04

torcetrapib and 1-anilino-8-naphthalenesulfonate

torcetrapib has been researched along with 1-anilino-8-naphthalenesulfonate in 2 studies

Compound Research Comparison

Studies
(torcetrapib)		Trials
(torcetrapib)		Recent Studies (post-2010)
(torcetrapib)		Studies
(1-anilino-8-naphthalenesulfonate)		Trials
(1-anilino-8-naphthalenesulfonate)		Recent Studies (post-2010) (1-anilino-8-naphthalenesulfonate)
273288324,2754807,815

Protein Interaction Comparison

ProteinTaxonomytorcetrapib (IC50)1-anilino-8-naphthalenesulfonate (IC50)
Chain A, RNA-directed RNA polymerase NS5Dengue virus 2 16681-PDK53100
Mitogen-activated protein kinase 14Homo sapiens (human)1.2

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenson, RS1
Grammer, TB; Kleber, ME; März, W1

Reviews

1 review(s) available for torcetrapib and 1-anilino-8-naphthalenesulfonate

ArticleYear
[High-density lipoprotein (HDL) and cholesteryl ester transfer protein (CETP): role in lipid metabolism and clinical meaning].
    MMW Fortschritte der Medizin, 2010, Jul-01, Volume: 152 Suppl 2

    Topics: Anticholesteremic Agents; Apolipoprotein A-I; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Diet, Fat-Restricted; Exercise; Humans; Lipase; Lipoproteins, HDL; Liver; Oxidative Stress; Phosphatidylcholine-Sterol O-Acyltransferase; Phospholipid Transfer Proteins; Quinolines; Triglycerides

2010

Other Studies

1 other study(ies) available for torcetrapib and 1-anilino-8-naphthalenesulfonate

ArticleYear
Functional assessment of HDL: Moving beyond static measures for risk assessment.
    Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:1

    Topics: Amides; Animals; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Esters; Ezetimibe; Glucose; Humans; Insulin; Lipase; Lipoproteins, HDL; Niacin; Quinolines; Risk Assessment; Risk Factors; Sulfhydryl Compounds

2010